VelosBio Investors

50 investors on Angel Roster list VelosBio in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, China and Israel.

Investors are matched on the company name in their portfolio, so companies that share the name VelosBio can appear together.

Investors listed
50
With verified email
52%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 40 VelosBio investors

The most complete profiles first. Showing 40 of 50.

  • Brett ZbarVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more

    Verified email available

  • Bryan RobertsVerified

    Venture Capital, Entrepreneurship Program, Private Equity Firm · United States

    Series BSeries AAdvertisingHealth CareTelecommunicationsWomen Founded

    Portfolio: Nightfall AI, Biolux Research, Cloudflare, Adavium and 82 more

    Verified email available

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Dennis RyanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Dorothy MargolskeeVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Ethan BatraskiVerified

    Venture Capital, Entrepreneurship Program, Private Equity Firm · United States

    Series BSeries AAdvertisingHealth CareRemote Work TechTelecommunications

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 66 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Harry BarberVerified

    Venture Capital, Investor · United States

    Series BSeries AHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Matt TaylorVerified

    Venture Capital, Advisor, Private Equity Firm · United Kingdom

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Nimish ShahVerified

    Venture Capital, Investor · United States

    Series AHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Rhonda KaufmanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Todd GrahamVerified

    Venture Capital, Investor · United States

    Series AHealth CareTelecommunicationsCybersecurityWomen Founded

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Victor TongVerified

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Alex RosenVerified

    Venture Capital · United States

    Health CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Claire ChinVerified

    Venture Capital · China

    Health CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Qiang XuVerified

    Venture Capital · China

    Health CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Wei XuVerified

    Venture Capital · China

    Health CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Andrew Gottesdiener

    Venture Capital, Investor · United States

    Series AHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • Dan Zabrowski

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Fang Yang

    Venture Capital, Private Equity Firm · China

    Early Stage VentureHealth CareInvestment ManagementChemicalLife Science

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Luke Bagaason, CFA

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Megan Blewett

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Nick Pliam

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Richard Lau, CFA

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Weizhi (Aaron) Li

    Venture Capital, Private Equity Firm · China

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Y. Katherine Xu

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

See all 50 VelosBio investors

Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.

Frequently asked questions

How many VelosBio investors are on Angel Roster?

Angel Roster lists 50 VelosBio investors. 26 of them (52%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (45), Private Equity Firms (25) and Entrepreneurship Programs (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do VelosBio investors invest in?

Among those that list a stage, the most common are Seed (18), Series A (11) and Early Stage Venture (6).

Where are VelosBio investors based?

Most are based in the United States (40), China (6) and Israel (2).

Which companies have VelosBio investors backed?

The most-backed portfolio companies among them are Olema Oncology (27), Keros Therapeutics (27), Visen Pharmaceuticals (19), ObsEva (19) and Terns Pharmaceuticals (19).

How do I contact VelosBio investors?

Create a free Angel Roster account to search and filter all 50, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.